Our guest on today’s show is Nancy Grden, the general manager for Genomind, a biotech company offering personalized medicine for neuropsychiatry, where she was instrumental in formation and launch. She is also the founder and president of Avenir, LLC, which specializes in entrepreneurship and innovation. Ms. Grden advises, consults, and serves as a board member for numerous new companies and university entrepreneurship programs, including USC’s Faber Entrepreneurship Center.
We invited Nancy to tell her story of how she ended up in the biotech space (one of the most difficult arenas for raising funds at the early stage) and how she was able to raise funds for Genomind. Tune in for Nancy’s detailed tips on how to make your presentation sound more appealing to investors. Hurry and Click “Play” below! The information in this episode is sure to change the funding game for you!
Listen To The Full Interview:
What You’ll Learn From This Episode:
- Nancy’s story of how she ended up in the biotech field.
- How Nancy realized she was ready to start looking for funding.
- The importance of knowing what you need when you are looking for funding.
- Why knowing your next steps and objectives is crucial for raising capital.
- What it means for a pitch to be compelling.
- How your pitch may vary depending on how many people you are pitching.
- What to expect during the due diligence process and how to avoid mistakes.
Featured On The Show:
- Crossing the Chasm by Geoffrey A. Moore
- Genomind on Linkedin, Twitter
- Nancy Grden: firstname.lastname@example.org
If you have questions about investing, early-stage capital raising, investor relationship and due diligence, post your question on The Pitch Deck Facebook Page. In our future episodes, we will read your questions and get feedback from our featured guests.